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Abstract
Colorectal cancer is one of the most serious illnesses among diagnosed cancer. As a new type of anti-cancer composition
from tocotrienol-rich fraction of palm oil, c-tocotrienol is widely used in anti-cancer research. The objectives of this study
were to investigate the effects of c-tocotrienol on human colon cancer SW620 and HCT-8 cells. We showed that treatment
with different concentrations of c-tocotrienol resulted in a dose dependent inhibition of cell growth. Cell death induced by
c-tocotrienol was mediated by a paraptosis-like cell death in SW620 and HCT-8 cells. Real-time RT-PCR and western blot
analyses showed that c-tocotrienol inhibited the expression level of b-catenin, cyclin D1 and c-jun. These data suggest that
a paraptosis-like cell death induced by c-tocotrienol in SW620 cells is associated with the suppression of the Wnt signaling
pathway, which offers a novel tool for treating apoptosis-resistance colon cancer.
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Introduction
Cancer is serious problems in public health, and has become
one of the main death causes all around the world. Among
diagnosed cancer, colorectal cancer is the third most common type
of cancer in men and the second in women worldwide, with
663,600 in men, 570,100 in women new colorectal cancer cases
and 320,600 in men, and 288,100 in women estimated deaths
occurred in 2008 [1]. The reasons that cause this kind of state are
varied, including overweight and obesity, physical inactivity,
changes in dietary patterns, and an increased prevalence of
smoking [2]. Most patients with colon cancer have accompanied
with the activation of the Wnt/b-catenin signal pathway [3,4]. In
a study [5], high activities of Wnt/b-catenin signaling pathway
could be one of the mechanisms that drive the colitis-to-cancer
transition in human colon.
Using the anti-cancer components in natural products to
intervene tumor occurrence and stop cancer from developing,
which is the filed for nutritionists to explore actively. One of
characteristic features of chemotherapeutic agents from natural
products is specific killing of malignant cancer cells but little
toxicity to normal cells. Some anti-cancer components, like
conjugated linoleic acid [6,7], b-ionone [8,9], curcumin [10],
berberine [11] are available from natural products. Tocotrienols,
a new potential natural chemotherapeutic agent, are abundant in
rye, barely, oat and palm oil [12]. Tocotrienols have been reported
to have a variety of therapeutic functions, including anti-oxidant
activity, anti-cancer activity, anti-angiogenic and immunomodu-
latory effects [13]. Tocotrienols, as a fat-soluble isomer of vitamin
E, absorbed in a similar fashion as fat from food in the intestines.
Their peaks in the blood are about 4 h after ingestion, and their
absorption is known to absorb more readily when taken along with
meals [14]. It is known that tocotrienols are one of kinds of
vitamins which are necessary in human being, rather than a kind
of pharmaceutical drugs. In a clinical trial study [15], tocotrienols
have the immunomodulatory effects in healthy women who taken
400 mg TRF-supplement (tocotrienol-rich fraction from palm oil)
daily when compared to the placebo group. A significantly
increasing plasma level of total vitamin E was found in the TRF-
supplemented group. Tocotrienols contain a-, b-, c-, and d-
homologues, with different number of methyl groups, and their
biological activities are also different, for example, c-tocotrienol is
more active than d-tocotrienol in Hela cells [16], while the anti-
cancer capacity of tocotrienols in prostate cancer cell lines is d-
tocotrienol.c-tocotrienol.b-tocotrienol.a-tocotrienol [17]. To-
cotrienols also may modulate various molecular targets, such as 3-
hydroxy-3-methyl-glutarylcoenzyme A (HMG-CoA) reductase,
inammatory transcription factors, and death receptors, at the
transcriptional, translational, post-translational levels [13]. c-
Tocotrienol also induced apoptosis in human gastric adenocarci-
noma SGC-7901 cells and human colon carcinoma HT-29 cells,
which is associated with suppression of the Raf-ERK signaling
pathway [18] and mitogen-activated protein kinase signaling
pathway [19], inhibitory effects on cell invasion and metastasis
[20,21]. However, the exact molecular mechanisms for cell death
induced by tocotrienols are still unclear.
Although many studies show that tocotrienols can induce
apoptosis in many kinds of malignant carcinoma cells by a cancer-
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apoptosis cell death through caspase-independent programmed
cell death (CI-PCD) in several types of cancer cells. Our previous
results have also demonstrated that d-tocotrienol induced a para-
ptosis-like cell death in human colon carcinoma SW620 cells [22].
Paraptosis, a new type of CI-PCD, is characterized mainly by
a process of cytoplasmic vacuolization [23]. Typical apoptotic
morphology, such as pyknosis, caspase activation and DNA
fragmentation, is absent in this form of cell death [24].
Vacuolation has been recognized as the results from swelling of
mitochondria and the endoplasmic reticulum (ER). AIP1/Alix,
a protein cloned from a calcium-binding protein involved in T-cell
receptor induced cell death, is the specific inhibitor for paraptosis
induced [24], which means that paraptosis requires protein
synthesis and transcription. Although paraptosis and paraptosis-
like processes have been described in various cell models, the exact
mechanisms underlying paraptosis are also still unclear.
PTX (paclitaxel), a kind of natural plant extract, is applied to
the cancer clinical treatments. PTX also shows induction of
apoptosis on several kinds of cancer cells such as colon cancer HT-
29 cell [25] and pancreatic cancer cells [26]. pone.0044418-
Handeli1In this study, we use the PTX as a negative control to
exam the effects of c-tocotrienol on cytoplasmic vacuolization. In
addition, in order to explain the relationship between the
paraptosis-like deaths in SW620 cells, FH535 which is an inhibitor
of the Wnt pathway was used in this study.
In this study, we investigated the effects of c-tocotrienol in
SW620 cells. In order to rule out the cell line-based bias, we
choose another colon cancer cells (HCT-8 cells) carry out some
parallel experiments. We observed the cytotoxicity and the
morphological changes when treated with c-tocotrienol. The
result showed that c-tocotrienol induced a paraptosis-like cell
death in SW620 cells characterized by a mass of cytoplasmic
vacuoles formation, which may associate with the suppression of
the Wnt signaling pathway.
Results
c-Tocotrienol Inhibited Cell Proliferation of SW620 Cells
The effect of c-tocotrienol on SW620 and HCF-8 cell
proliferation was examined by MTT assay. As shown in Fig. 1,
c-tocotrienol significantly inhibited cell growth in SW620 and
HCF-8 cells in a dose-dependent manner (p,0.05). The inhibitory
rates of c-tocotrienol on SW620 cells for 24 h were 77.5% at dose
of 60 mmol/L when compared to the control group. The IC50
value of c-tocotrienol was 31.461.51 mmol/L in SW620 cells and
32.6961.29 mmol/L in HCT-8 cells. In the meantime, the cell
viability of PTX in SW620 cells also was determined in this study.
The results showed that PTX significantly inhibited cell growth in
SW620 cells in a dose-dependent manner (p,0.05).
c-Tocotrienol Induced Paraptosis-like Cell Death
Cell death was further investigated in SW620 and HCT-8 cells
in this study. The results are shown in Fig. 2 and 3. Microscopic
findings showed that the cells showed a spindly and large and grew
close together, with prominent nucleoli and abundant cytoplasm
in control group and the treated cells grew slowly and loosed tight
contacts amongst cells (Fig. 2 and 3I). In addition, we also
observed reduction of cell size, turn round of cell shape and
cytoplasmic vacuolar in treated SW620 cells. The cells treated
with c-tocotrienol at dose of 60 mmol/L for 6 and 24 h showed
a cytoplasmic vacuolization and the dead cells with extensive
cytoplasmic vacuolization, respectively. The same phenomenon of
cellular morphological changes also was observed in FH535
treated groups (Fig. 2I).
To better understand cellular morphological changes induced
by c-tocotrienol, SW620 and HCF-8 cells were analyzed by
staining DAPI or AO/EB dyes or transmission electron microcopy
(TEM). As shown in Fig. 2 and 3 II, the cells were no obvious
changes on cell nucleus accompanying with increasing concentra-
tion of c-tocotrienol. After were exposed to c-tocotrienol for 6 h,
SW620 cells showed an intracellular vacuolization appeared on
the black background (Fig. 2 II F). Interestingly HCT-8 cells also
showed an intracellular vacuolization appeared on the black
background when treated with c-tocotrienol (Fig. 3 II B). The
results of AO/EB staining are shown in Fig. 2 III. The treated cells
did not show a typical apoptosis such as apoptosis body and
chromatin condensation. After c-tocotrienol treatment at dose of
60 mmol/L for 6 and 24 h, cells showed numerous vacuoles (Fig. 2
III F) and high degree of cell rounding and large vacuoles (Fig. 2
III E), respectively. The same phenomenon of cellular morpho-
logical changes also was observed in the FH535 treated group.
However, they did find evident cellular morphological changes in
the PTX treated group when compared to the FH535 group
(Fig. 2II).
In order to detect the c-tocotrienol-induced vacuoles in SW620
cells, the transmission electron microscopy (TEM) was emplyeed
to observe the cellular ultrastructures. The results showed that
swelling of the mitochondria and/or endoplasmic reticulum (ER)
was detected in the cells treated with c-tocotrienol (Fig. 4). The
characteristics of classic apoptosis did not found in this study. The
cells showed intact and clear organs in the control group. After
treatment for 24 h, swell and formed megamitochondria were
observed in the cells treated with 15 or 30 mmol/L of c-tocotrienol
groups (Fig. 4 B and C). The rates of fusion of megamitochondria
and/or ER decreased and the number of vacuoles increased in the
cells treated 45 and 60 mmol/L of c-tocotrienol groups (Fig. 4D).
In addition, after treatment 6 h, a plenty of large or small
cytoplasmic vacuoles were observed in the cells treated with
60 mmol/L of c-tocotrienol (Fig. 4 F). Taken together, these results
demonstrate that c-tocotrienol induces paraptosis-like cell death in
SW620 cells.
Determination of Cell Growth State Distribution and
Activated Caspase-3
We further examined the cell growth state distribution and
activation of caspase-3 in SW620 cells treated with c-tocotrienol
for 24 h. The cell growth state distribution was determined by flow
cytometry. By using the Annexin V-EGFP and PI dye, SW620
cells were divided into three types including viable cells (annexin
V-EGFP
–,P I
–), non-viable necrotic cells in late apoptotic cells
(annexin V-EGFP
+,P I
+) and early apoptotic cells (annexin V-
EGFP
+,P I
–). As shown in Fig. 5 and Fig. 6, the proportion of early
apoptotic cells was below 6.0% in all groups, and a peak of cell
death was found in SW620 cells treated with 60 mmol/L of c-
tocotrienol. In order to determine caspase-3 activation, SW620
cells were pre-treated with z.VAD.fmk, a pan-specific caspase
inhibitor and then treated with different concentrations of c-
tocotrienol for 24 h. The rate of cell viability was measured in the
treated and control groups (Fig. 7). The results showed that the
percentage of viable cells was declined in all groups, and c-
tocotrienol had the same effect on SW620 with/without
z.VAD.fmk. It indicated that c-tocotrienol-induced cell death is
caspase-independent. Caspase-3 activation was also examined in
this study. The relative ratios of caspase-3 activation were
74.365.2, 72.967.3, 72.466.3 and 78.665.8% in SW620 cells
treated with 15, 30, 45 and 60 mmol/L of c-tocotrienol,
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treated groups and the control group (P.0.05). As shown in Fig. 6
II, the caspase-3 activity also determined in HCT-8 cells after
treated with different doses of c-tocotrienol (10, 20, 30 and
40 mmol/L). The results showed that c-tocotrienol-induced cell
death in HCT-8 cells was also caspase-independent. In the
meantime, DNA ladder assay also used to determine apoptosis in
this study. The results showed that PTX at doses of 1.0 and
1.5 mmol/L induced the formation of DNA ladder in SW620 cells.
c-Tocotrienol did not induce the formation of DNA ladder in
SW620 cells (Fig. 6 III).
c-Tocotrienol Affected the Protein Expression of Wnt
Signaling Pathway
Own to Wnt signaling pathway playing a critical role in tumor
occurrence and development, the effects of c-tocotrienol was
investigated in SW620 cells by real-time PCR and western blot.
The mRNA expression levels of Wnt-1, b-catenin, c-jun and cyclin
D1 are shown in Fig. 8. b-Catenin, c-jun and cyclin D1 expression
showed a decrease accompanying with the increasing concentra-
tions of c-tocotrienol. The mRNA levels of c-jun and cyclin D1
were significantly decreased in SW620 cells treated with 45 or
60 mmol/L of c-tocotrienol when compared to the control group
(P,0.05). Although the mRNA expression of Wnt-1 at dose of
15 mmol/L group was slightly higher than that in the control
group, there was no differences (P.0.05). This result indicated
that c-tocotrienol had no effect on the mRNA expression of Wnt-
1.
We further examined whether protein expression associated
with Wnt signaling pathway were modulated by c-tocotrienol. As
shown in Fig. 9, c-tocotrienol significantly down-regulated the
protein expression of Wnt-1 and b-catenin as well as the
downstream target proteins of Wnt signaling pathway such as c-
jun and cyclin D1 in a dose-dependent manner (p,0.05 or
p,0.01). In addition, PTX at doses of 0.8 and 1.2 mmol/L
significantly increased b-catenin protein expression and FH535
significantly decreased b-catenin protein expression in SW620
cells.
Discussion
Anti-cancer agents found in natural products have been
reported to preferential killing of cancer cells [27]. As one of the
most important components of vitamin E, tocotrienols are the
main bioactive components in palm oil, which not only has higher
antioxidant potential but also more other bioactivity than
Figure 1. The cell viability of SW620 cells and HCT-8 cells. The panels showed c-tocotrienol (I) and PTX (II) in SW620 cells and HCT-8 cells (III).
The cells were treated with various concentrations of c-tocotrienol or PTX for 24 h. Cell viability was determined by MTT assay. Data were expressed
as means 6 standard deviation (n=6). *P,0.05, compared to the negative control group.
doi:10.1371/journal.pone.0057779.g001
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[28]. Many studies have been reported tocotrienols and toco-
trienol-rich fraction from palm oil (TRF) can kill several kinds of
malignant carcinoma cells inhibit the growth of many kinds of
tumors in animals [29–31]. TRF can not only inhibit tumor
growth by reducing revascularization [29], but also affect tumor
gene expression in the nude mouse body inoculated by MCF-7
cells [30]. TRF also showed an evident up-regulation of the
interferon-inducible transmembrane protein-1 gene and the CD59
glycoprotein precursor gene in TRF-treated animals in compar-
ison with controls [30]. Another study showed that c-tocotrienol
could inhibit SGC-7901 cell growth and increase the chemosensi-
tization of capecitabine in a xenograft mouse model through the
modulation of NF-kB pathway [31].
Tocotrienols can induce different types of cancer cell death. A
series of studies show that tocotrienols induce apoptosis in many
cancer cells, such as MDA-MB 231 and MCF-7 breast cancer cells
[32], PC-3 and LNCaP prostate cancer cells [33] and non-small
cell lung cancer cells [34]. In a previous study, c- and d-
tocotrienols induced CI-PCD in prostate cancer cell lines by
inactivation of caspase-3/8 [17] and caspase-independent DNA
damage [35]. Several evidences show that tocotrienols can induce
autophagy [33,36,37]. c-Tocotrienol induced autophagy in
prostate cancer cells by elevation of intracellular dihydroceramide
and dihydrosphingosine [33]. In another study, tocotrienols
induced autophagy in rat pancreatic stellate cells through the
mitochondrial death pathway [37]. In addition, c-tocotrienol also
induced typical morphological characteristics of apoptosis in
MDA-MB-231 human breast cancer cells, with no change of
bax and bcl-2 expression and absence of poly-(ADP-ribose)-
polymerase cleavage [36]. Therefore, these studies indicated that
an alternative CI-PCD may be involved in the cell death induced
by tocotrienols.
Tocotrienols have a-, b-, c- and d-tocotrienol isomers. Previous
studies have shown that the isoforms of tocotrienols have different
biological activities. The anti-cancer capacity of these isomers on
human hepatocellular carcinoma HepG2 cells is d-tocotrienol.b-
tocotrienol.a-tocotrienol < c-tocotrienol [38]. d-Tocotrienol has
a higher activity than other tocotrienols on reducing fibroblast
growth factor-induced proliferation, migration, and tube forma-
tion in HUVEC [39]. Our previous study showed that d-
tocotrienol inhibited cell proliferation of SW620, and the IC50
value was 15.2 mmol/L [22]. c-Tocotrienol and a-tocotrienol are
more potent than d-tocotrienol on the antiproliferative effect on
human cervical carcinoma (Hela) cells, with the
IC50:2.8560.07 mmol/L, 3.1960.05 mmol/L and .100 mmol/
L, respectively [16]. Another study showed that c-tocotrienol is
more active than a-tocotrienol and d-tocotrienol on inducing
apoptosis in human hematological cancer cell lines [40]. In our
previous study, c-tocotrienol inhibited cell proliferation in human
colon carcinoma HT-29 cells (IC50:31.7 mmol/L) [41] and
human gastric adenoma carcinoma SGC-7901 cells
(IC50:61.88 mmol/L) [42]. Compared with IC 50 dosage of
induction cell death of tocotrienols in human colon carcinoma
SW620 cell, c-tocotrienol is larger than that in d-tocotrienol.
Thus, c-tocotrienol had a weak cytotoxic effect on SW620 cells in
comparison with d-tocotrienol’s. It may be the reason to explain
why c-tocotrienol and d-tocotrienol are different because of their
different stereochemical structure. In addition, tocotrienols at
micromole dosage inhibit the proliferation of cancer cells and no
Figure 2. The morphological changes of cell death in SW620
cells treated with c-tocotrienol, FH535 or PTX. SW620 cells were
treated with c-tocotrienol, FH535 or PTX for 6 and 24 h. The
morphological changes of SW620 cells were detected under a light
microcopy (I, Magnification: 6100), a fluorescent microscope stained
with DAPI (II, magnification:6200) and AO/EB (III, magnification:6100).
The cells treated with control (A), 15 (B), 30 (C), 45 (D) and 60 mmol/L (E)
for 24 h as well as 60 mmol/L of c-tocotrienol (F) for 6 h, or the cells
treated with PTX at doses of 0(A), 0.2(B), 0.4(C), 0.8(D), 1.2(E) mmol/L, or
FH535 at doses of 0(A), 0.625(B), 1.25(C), 2.5(D) mmol/L and DMSO (E) for
24 h. After treatment, the cells showed the slow growth, loosed tight
contacts amongst cells and reduction of cell size, turn round of cell
shape and cytoplasmic vacuolar when compare a spindly and large and
grew close together, with prominent nucleoli and abundant cytoplasm
in control group. Red arrows indicate the vacuoles.
doi:10.1371/journal.pone.0057779.g002
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induced either no or low levels of apoptosis in normal human
mammary epithelial cells and immortalized but no tumorigenicity
in human MCF-10A cells [43]. c-Tocotrienol showed no
cytotoxicity on normal human peripheral blood mononuclear
cells, suggesting that tocotrienols have a differential cytotoxicity
towards normal lymphocytes and transformed lymphoma cells
[44].
Classical apoptosis is caspase-dependent programmed cell death
(CD-PCD). While accumulating evidence in the literature supports
that several types of caspase-independent programmed cell death
(CI-PCD) exist in the cells, such as autophagy, cornification,
mitotic catastrophe, anoikis, paraptosis, excitotoxicity, Wallerian
degeneration and programmed necrosis [45]. Therefore, it may be
a new way for treating malignant cells to understand the exact
mechanism on the different types of CI-PCD. In our study, c-
tocotrienol induced vacuolation before cell death in SW620 and
HCF-8 cells, with no characteristics of apoptosis, such as cellular
shrinkage, apoptotic bodies and activation of caspase-3. Moreover,
TEM analysis revealed that vacuolation in SW620 cells came from
the swelling and subsequent fusion of mitochondria or ER. In
addition, the pan-caspases inhibitor z.VAD.fmk had no effect on
c-tocotrienol-induced cell death and the rates of early apoptosis in
c-tocotrienol treated were similar to that of the control group.
These suggest that this kind of cell death induced by c-tocotrienol
is different from apoptosis.
Because of the instability of cancer cells, the mutations are often
occurred, leading resistance of cancer cells to current anti-
apoptosis therapies. Therefore, CI-PCD may play an important
role in inducing cell death and be the major death style in many
tumor cells [46]. Many natural anti-cancer substances from food
such as curcumin [47], b-ionone [48], conjugated linoleic acid
[49], taxol [50], ginsenoside Rh2 [51], as well as other
chemotherapeutic agents [52] like doxorubicin, paclitaxel, can
induce CD-PCD and CI-PCD in cancer cells.
The cross-talk between cell death signaling pathways may play
an important role in switching cell death among the death
programs. It is reported that more than one kind of cell death
program may be activated at the same time in the same cells [53].
The dominant cell death phenotype is determined by the fastest
and most effective pathway on the available death programs [52].
According to this, paraptosis is the dominant cell death in c-
tocotrienol-induced cell death in SW620 cells. In addition,
organelles such as the mitochondria and ER are reported to play
a prominent role in paraptosis [24,51,54]. In our study, our results
showed that c-tocotrienol induced a paraptosis-like cell death in
human colon carcinoma SW620 cells. Furthermore, we further
determined the possible molecular mechanism of cell death
induced by c-tocotrienol in human colon cancer SW620 cells.
The Wnt signaling pathway plays very important roles in stem
cell maintenance, cell proliferation and differentiation regulation
[55]. It is also known that the Wnt signaling pathway participates
in tumorigenesis in many human cancers, including colon cancer,
breast cancer, lung cancer, melanomas, and hepatocellular
carcinoma[56–61]. The Wnt signaling pathway is activated in
approximately 90% of human colorectal cancer [4] and crucial for
colon cancer stem cells [62]. The level of b-catenin controls the
canonical pathway and is regulated by the destruction complex,
consisting of two ser/thr kinases, GSK-3b (glycogen synthase
kinase-3b) and CKI, two scaffold proteins, Axin and APC
(adenomatous polyposis coli) [63]. When the Wnt/wg ligand is
absent, Axin complex in the cytoplasm showing a stable state,
CK1a, GSK-3b in this complex sequentially phosphorylated b-
Catenin. Phosphorylated b-Catenin could be recognized by the E3
ubiquitin ligase enzyme b-Trcp, and then be de-gradated by
proteasome, to ensure the concentrate of the b-catenin maintained
at a relatively low level [58]. Once Wnt signaling is activated, Axin
complex depolymerization, b-catenin in cytoplasm has the chance
of cumulate, and then combine with the TCF (T-cell factor) in cell
nuclear to activate the Wnt gene. The activated Wnt genes result
in inducing the downstream genes (such as c-jun and c-myc)
transcription which are associated with malignancy, and ultimate
affect the activities of cell [64]. The Wnt antagonists are divided
into two categories: one direct bind to Wnt to inhibit the Wnt
Figure 3. The morphological changes of cell death in HCT-8 cells. HCT-8 cells were treated with 0, 20, and 40 mmol/L of c-tocotrienol for
24 h. The morphological changes of HCT-8 cells were detected under a light microcopy (I, Magnification:6200). The cells were stained with DAPI (II,
Magnification: 6200). Both figure showed that the cells treated with control (A), 20 (B), 40 mmol/L(C) for 24 h. Arrows indicate the vacuoles.
doi:10.1371/journal.pone.0057779.g003
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PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e57779Figure 4. Morphological changes of paraptosis-like cell death were observed in SW620 cells by transmission electron microscopy
(TEM). After treatment with 15 (B), 30 (C), 45 (D) and 60 mmol/L (E) of c-tocotrienol for 24 h, SW620 cells showed the swelling of mitochondria or ER
(red arrowheads) and extensive cytosolic vacuolization (red arrows). The micrographs (A) provided normal cells control. The significant swellingso f
mitochondria or ER were observed after treated with 60 mmol/L of c-tocotrienol for 6 h (F).
doi:10.1371/journal.pone.0057779.g004
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1 and Cerberus; the other combines writ receptor composite
LRPS/LRP6 to inhibit the Wnt signaling pathway. Especially,
SFRPs were admitted as a family of new colorectal tumor
suppressor candidate genes [65]. SFRP-1 and the SFRP-like
molecule V3Nter can inhibit Wnt signaling and expression of the
b-catenin target genes - cyclin D1 and c-myc, finally inhibiting
tumor growth of b-catenin-activated tumor cells such as colon
cancer SW480 and HCT-116 cells [66]. Therefore, the Wnt/b-
catenin signaling pathway is an attractive target for new
therapeutics. A series of our previous studies showed that
tocotrienols mediated grow inhibition on human colon cancer
cells that related with suppressing the activity of Wnt signaling
pathway [21,22]. However, there are no further information about
the mutation status of the APC gene and b-catenin gene in SW620
cells.
FH535, a kind of cell permeability sulfa compound, could
inhibit the Wnt/b-catenin pathway by the function of inhibiting
the b-catenin recruitment. In a previous study [67], H535 at the
dose of 15 mmol/L could down-regulate b-catenin expression in
HCT-116 and SW48 cells. FH535 at the dose of 0.1 mmol/L also
showed to inhibit migration and growth of breast cancer cells [68].
Recent studies have demonstrated that FH535 is a synthetic
inhibitor of the canonical WNT-signaling pathway and, not for
Figure 5. Cell death was examined in SW620 cells by flow cytometry. The cells treated with 0 (A), 15 (B), 30 (C), 45 (D) and 60 mmol/L (E) of c-
tocotrienol for 24 h. The percentage of early apoptosis was obtained from lower right quadrant (annexin V-EGFP
+,P I
–). *P,0.05, compared to the
same dose of each group.
doi:10.1371/journal.pone.0057779.g005
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PLOS ONE | www.plosone.org 7 February 2013 | Volume 8 | Issue 2 | e57779Figure 6. The cellular caspase-3 activity and DNA ladder were examined in SW620 cells or HCT-8 cells. The cellular caspase-3 activity
was determined in SW620 cells (I) and HCT-8 cells (II) treated with different doses of c-tocotrienol as well as DNA ladder in SW620 cells treated with
PBS (A), 1.0 and 1.5 mmol/L of PTX or c-tocotrienol (D) for 24 h. There are no difference between the treated and control groups.
doi:10.1371/journal.pone.0057779.g006
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hepatocellular carcinoma cell lines [67]. In our study, c-tocotrienol
could induce both SW620 and HCT-8 cells death in a type of
cytoplasmic vacuolization, and this kind of death did not accord
with the typical characters of apoptosis. At the same time the c-
tocotrienol decreased the level of b-catenin in SW620 cells both in
protein and mRNA levels. As the target factors, c-jun and cyclin
D1 are known to regulate cell growth and vitality and apoptosis
[69], c-tocotrienol also significantly decreased the mRNA and
protein expression of c-jun and cyclin D1 in this study. When
treated with PTX, the SW620 cells showed the characterics of
apoptosis like DNA Ladder. But the level of b-catenin at dose of
less 0.8 mmol/L PTX was decreased in SW620 cells. In order to
detect the role of Wnt pathway and the relationship between the
death of paraptosis in a type of cytoplasmic vacuolization and the
Wnt pathway in SW620 cells, a Wnt/b-catenin inhibitor FH535
was used in this study. FH535 could induce SW620 cells death
with cytoplasmic vacuolization, and decrease the level of b-catenin
protein in the cells. This result indicates that there may be some
common ground between c-tocotrienol and Wnt/b-catenin in-
hibitor in the mechanism of induce the SW620 cells paraptosis-like
death. Bap31 from an endoplasmic reticulum (ER) localized
polytopic transmembrane (TM) protein, bax/bax and p20Bap31
(p20) fragment plays a variety of roles in trafficking and quality
control paraptosis-like form of cell death [54]. In our previous
study, d-tocotrienol induced paraptosis-like death correlated with
the vacuolation that may be from welling and fusion of
mitochondria and/or the ER in SW620 cells [22]. Wnt signaling
is regulated by ER retention in the mouse embryo [70]. Thus, the
paraptosis-like death may be related to Wnt signaling via
a regulation of ER. Taken together, our data suggested that cell
death induced by c-tocotrienol in human colon carcinoma SW620
cells is associated with the suppression of the Wnt signaling
pathway by a regulation of ER.
Methods
Chemicals and Reagents
c-Tocotrienol (97%) was purchased from Davos Life Science
(Singapore). 3-(4,5- dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT), ethidium bromide (EB), and acridine Orange
(AO) were purchased from Sigma Chemical Co.(St. Louis, MO).
49, 6-Diamidino-2-phenylindole (DAPI) was obtained from Roche
Applied Science (Indianapolis, IN). The caspase inhibitor -
benzyloxycarbonyl-Val-Ala-Asp (OMe) uoromethylketone
(z.VAD.fmk), the Caspase-3 Colorimetric Assay kit and Annexin
V-EGFP (enhanced green fluorescent protein) Apoptosis Detection
kit were bought from Nanjing Keygen Biotech. Co., Ltd.
(NanJing, China). Anti-b-actin, anti-Wnt-1, anti-b-catenin, anti-
cyclin D1, and anti-c-jun antibodies were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). Mouse IgG HRP –
and rabbit IgG HRP – secondary antibodies were purchased from
Promega (Madison, WI). Real-Time PCR Reagents and Kits were
obtained Invitrogen Corporation (Carlsbad, CA). PTX (paclitaxel)
and the DNA Ladder Assay Kit were bought from the ZSGB-BIO
Company (TianJing, China) and FH535 from Sigma Chemical
Co. (St. Louis, MO). All reagents were of analytical grade unless
noted.
Figure 7. The cell viability of c-tocotrienol with or without
z.VAD.fmk. The SW620 cells were treated with different doses of 15,
30, 45 and 60 mmol/L of c-tocotrienol with or without z.VAD.fmk for
24 h. The cell viability was examined by MTT assay. *P,0.05, compared
to the control group.
doi:10.1371/journal.pone.0057779.g007
Figure 8. The mRNA expression levels of Wnt-1, b-catenin, c-jun and cyclin D1 were detected in SW620 cells treated with different
concentration of c-tocotrienol by RT-PCR. c-Tocotrienol significantly decreased the mRNA expression of b-catenin, c-jun and cyclin D1 in SW620
cells (P,0.05).
doi:10.1371/journal.pone.0057779.g008
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of 1.0 mol/L stock solution and stored in dark place at 220uC.
The stock solution was diluted to required concentration and
stored at 4uC. Experiments were independently carried out at least
three times.
Cell Culture
Human colon carcinoma SW620 and HCF-8 cell lines were
obtained from the Cancer Institute of Chinese Academy of
Medical Science (Beijing, China) [71,72]. The SW620 cells were
cultured in L-15 medium and HCF-8 cells with DMEM/F12
containing 2 mmol/L L-glutamine, and 2 g/L sodium bicarbon-
ate (Gibco, NY), supplemented with antibiotics (100 U/mL of
penicillin and 100 mg/mL of streptomycin), 10% fetal bovine
serum (FBS, Gibco) at 37uC in a humidified atmosphere with 95%
air and 5% CO2. Before subculturing, cells were digested in 0.25%
trypsin containing 0.02% EDTA.
Cytotoxicity Assay
The inhibitory growth of c-tocotrienol and PTX on SW620 and
HCF-8 cells was evaluated according to MTT assay [21,73].
SW620 or HCF-8 cells (1610
5 cells/well) were seeded into 96-well
plates. After 24 h, cells were incubated with 200 mL of fresh
complete culture medium containing 5, 10, 15, 20, 25, 30, 40, 50,
60, 70, 80, 90 and 100 mmol/L of c-tocotrienol or 0.25, 0.5, 1.0,
1.5, 2.0, 2.5, 3.0 and 3.5 mmol/L of PTX. The negative control
group was treated with 100% ethanol (0.1%v/v). Each concen-
tration of c-tocotrienol was repeated in six wells. After incubation
for 20 h, 20 mL of 1 mg/ml MTT solution in phosphate-buffered
saline (PBS) was added to each well. After 4 h, we discarded the
medium carefully. Then, 200 mL dimethyl sulfoxide (DMSO) was
added to each well. After shaking quickly for 15 sec, the
absorbance was measured at weave length of 495 nm in
a Multiskan Ascent plate reader (Thermo Labsystems, Helsinki,
Finland).
Morphological Analyses
The SW620 cells were plated in 24-well plates at 5610
5 cells/
well. After 24 h, the cells were treated with fresh L-15 medium
containing 0, 15, 30, 45 and 60 mmol/L of c-tocotrienol, or 0.625,
1.25, and 2.5 mmol/L of FH535, or 0.2, 0.4, 0.8, and 1.2 mmol/L
of PTX. After being treated with c-tocotrienol for 6 or 24 h, the
cells were fixed using methanol. The cells were washed PBS once,
treated with DAPI-methanol (1 mg/ml of working solution) and
incubated for 15 min at 37uC. The staining solution was then
discarded. In the meantime, HCT-8 cells were stained with DAPI
solution after c-tocotrienol treatments. For AO/EB staining assay,
after treatment as indicated DAPI staining assay, the cells were
washed with PBS twice and stained with AO/EB solution
(100 mg/ml of AO and 100 mg/ml of EB in PBS) for 10 sec at
room temperature away from light. The stained cells were
examined through a fluorescence microscope (IX70, Olympus,
Japan).
For transmission electron microscopy analysis (TEM), we have
described in previous study [22,74]. Briefly, after treated with c-
tocotrienol for 6 and 24 h, respectively, the cells were collected,
washed with PBS, and fixed in 4% glutaraldehyde phosphate
buffer for 24 h at 4uC, followed by 1% osmium tetroxide fixation
for 1 h at 4uC and dehydration in graded ethanol solutions.
Ultrathin sections counterstained with uranyl acetate and lead
citrate were examined under a JEM-1220 TEM (JEMOL, Japan).
Determination of Cell Death
For the effect of the caspase inhibitor z.VAD.fmk on c-
tocotrienol, the z.VAD.fmk was added to each well at the
concentration of 20 mmol/L, with cells continuing to incubate for
10 min. SW620 or HCT-7 cells were then treated with 15, 30, 45
and 60 mmol/L of c-tocotrienol for 24 h. Cell death was
determined as described in Section of cytotoxicity.
Figure 9. The protein expressions of Wnt-1, b-catenin, c-jun,
cyclin D1 and b-actin in SW620 cells. The cells treated with 15, 30,
45 and 60 mmol/L of c-tocotrienol (A and B), or PTX at 0.2, 0.4, 0.8 and
1.2 mmol/L (C), or FH535 at 1.25, 2.5, 5 and 15 mmol/L for 24 h (D).
*P,0.05, compared to the negative control group.
doi:10.1371/journal.pone.0057779.g009
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different concentrations of c-tocotrienol for 24 h. The activity of
caspase-3 was detected according to manufacturer’s instruction.
DNA Ladder Assay
After PTX treatments, SW620 cells were scraped and collected
from culture dishes in ice cold PBS. After centrifugation, the cell
pellets were lysed in lysis buffer and centrifuged for 5 min at
10006g. The supernatant from each sample was collected and
DNA was extracted using the assay kit. The DNA samples were
electrophoresed in 2% sepharose gel. The DNA bands were
analyzed using Gel Documentation and Analysis System.
For FACS analysis, after treatment with various concentrations
of c-tocotrienol for 24 h, 1610
6 cells (including the adherent and
detached cells) were collected and washed three times with PBS.
The cells were resuspended in 500 mL binding buffer, followed by
adding 5 mL Annexin V-EGFP and 5 mL propidium iodide (PI)
and incubating for 15 min at room temperature. Cell death was
performed by a FACSCalibur flow cytometry (Becton and
Dickinson, CA) with excitation using a 488 nm argon ion laser.
Quantitative Real-time RT-PCR Reaction
SW620 cells were treated with 0, 15, 30, 45 and 60 mmol/L of
c-tocotrienol for 24 h. Total RNA from cells were extracted using
TRIzolH Reagent (Invitrogen) and first strand cDNA was
synthesized from 5 mg of total RNA of each sample utilizing
SuperScrip III reverse transcriptase (Invitrogen). The sequences of
primers are shown in Table 1.
For quantitative real-time PCR, the reactions were performed
with SYBR Green I (Invitrogen) according the manufacturer’s
instructions. The PCR amplification conditions were as follows:
pre-denaturation for 2 min at 95uC; PCR amplification for 40
cycles with denaturation for 10 sec at 95uC, annealing tempera-
ture for 30 sec at 60uC, extension for 30 sec at 68uC in a iQ5 real-
time PCR System (BIO-RAD). The reaction specificity was then
determined by a melt curve analysis. Relative amounts of cDNA
were analyzed with the DDCt method.
Western Blot Analysis
After c-tocotrienol or PTX, or FH535 treatments, SW620 cells
were scraped from culture dishes in ice cold PBS and were
harvested by centrifuging. The collected cells were lysed in lysis
buffer (SBS Genetech Co., Ltd). Fifty microgram of total protein
was separated by 10–12% SDS–PAGE gel, and transferred onto
a PVDF membrane (Millipore). The membranes were block with
5% non-fat milk in Tris-Buffered Saline Tween-20 (TBST, 1%
Tween-20 in 20 mmol/L TBS, pH 7.6). The membrane was
probed with specific antibodies (anti-b-actin, anti-wnt-1, anti-b-
catenin, anti-cyclin D1, or anti-c-jun). The membrane was
incubated with horseradish peroxidase - conjugated anti-rabbit
or anti-mouse secondary antibody for 1 h at room temperature.
Protein bands were visualized using a ECL kit (Santa Cruz). The
protein bands were measured by FluorChem Imaging Systems
(Alpha Innotech).
Statistical Analysis
All data are expressed as means 6 standard deviation (SD). The
differences between the control and treated groups were assessed
by one-way ANOVA test followed by Student-Newman - Keuls
(SNK) test. Differences were considered significant at P,0.05.
Conclusions
c-Tocotrienol inhibited cell proliferation and induced a para-
ptosis-like cell death in human colon cancer cell lines both in
SW620 and HCT-8. This anti-proliferative effect may at least
partly involve in the suppression of the Wnt signaling pathway.
Our findings suggest that c-tocotrienol may be a potential natural
reagent to prevent and treat apoptosis-resistance colon cancer.
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